Diphenylhydantoin inhibits the thyrotropin response to thyrotropin-releasing hormone in man and rat

Martin I. Surks, K. W. Ordene, D. N. Mann, M. H. Kumara Siri

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

We studied the effect of diphenylhydantoin (DPH) on TRH-stimulated TSH secretion in four patients (three of whom had hypothyroidism; one treated with L-T4), in euthyroid rats, and in dispersed rat anterior pituitary cells in short term tissue culture. DPH treatment of four patients (100 mg, three times daily for 14 days) caused a 22% decrease in mean serum T4 (P < 0.06), a 31% decrease in mean serum free T4 (P < 0.01), and a 6% decrease in mean serum T3. Mean basal serum TSH was unchanged, but the integrated TSH response after TRH injection (500 μg, iv) decreased 28% (P < 0.06) and 51% (P < 0.01) after 7 and 14 days of DPH treatment, respectively. Changes in the integrated PRL response to TRH did not correlate with those in TSH. Injection of DPH into euthyroid rats (5 mg/100 g BW.day for 9 days) caused a significant decrease in mean serum T4 but no changes in TSH release after TRH treatment. However, 1 h after a large dose of DPH (20 mg/100 g BW), there was a marked reduction (58%) in TRH-induced TSH release. DPH injections into athyreotic rats (5 mg/100 g BW every 8 h for 48 h) caused a significant increase in pituitary TSH (P < 0.01) but no significant decrease in plasma TSH. DPH inhibited TSH release from cultured anterior pituitary cells. In the presence of 10-7 M TRH, DPH (10-4 M) caused a 74% decrease in TSH release (P < 0.001); the inhibition produced by T3 (10-7 M) was only 14% (P < 0.05). These studies suggest that DPH inhibits TRH-induced TSH release in man, euthyroid rats, and cultured rat interior pituitary cells. Thus, in DPH-treated patients with decreased serum T4 and free T4, the observed normal serum TSH when one would expect elevated serum TSH may result from drug-induced inhibition of TRH action on TSH release.

Original languageEnglish (US)
Pages (from-to)940-945
Number of pages6
JournalJournal of Clinical Endocrinology and Metabolism
Volume56
Issue number5
StatePublished - 1983

Fingerprint

Thyrotropin-Releasing Hormone
Phenytoin
Thyrotropin
Rats
Serum
Injections
Tissue culture
Hypothyroidism
Therapeutics
Plasmas

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Diphenylhydantoin inhibits the thyrotropin response to thyrotropin-releasing hormone in man and rat. / Surks, Martin I.; Ordene, K. W.; Mann, D. N.; Kumara Siri, M. H.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 56, No. 5, 1983, p. 940-945.

Research output: Contribution to journalArticle

@article{46ac4b26d49b48a08ef871ceccf91ad5,
title = "Diphenylhydantoin inhibits the thyrotropin response to thyrotropin-releasing hormone in man and rat",
abstract = "We studied the effect of diphenylhydantoin (DPH) on TRH-stimulated TSH secretion in four patients (three of whom had hypothyroidism; one treated with L-T4), in euthyroid rats, and in dispersed rat anterior pituitary cells in short term tissue culture. DPH treatment of four patients (100 mg, three times daily for 14 days) caused a 22{\%} decrease in mean serum T4 (P < 0.06), a 31{\%} decrease in mean serum free T4 (P < 0.01), and a 6{\%} decrease in mean serum T3. Mean basal serum TSH was unchanged, but the integrated TSH response after TRH injection (500 μg, iv) decreased 28{\%} (P < 0.06) and 51{\%} (P < 0.01) after 7 and 14 days of DPH treatment, respectively. Changes in the integrated PRL response to TRH did not correlate with those in TSH. Injection of DPH into euthyroid rats (5 mg/100 g BW.day for 9 days) caused a significant decrease in mean serum T4 but no changes in TSH release after TRH treatment. However, 1 h after a large dose of DPH (20 mg/100 g BW), there was a marked reduction (58{\%}) in TRH-induced TSH release. DPH injections into athyreotic rats (5 mg/100 g BW every 8 h for 48 h) caused a significant increase in pituitary TSH (P < 0.01) but no significant decrease in plasma TSH. DPH inhibited TSH release from cultured anterior pituitary cells. In the presence of 10-7 M TRH, DPH (10-4 M) caused a 74{\%} decrease in TSH release (P < 0.001); the inhibition produced by T3 (10-7 M) was only 14{\%} (P < 0.05). These studies suggest that DPH inhibits TRH-induced TSH release in man, euthyroid rats, and cultured rat interior pituitary cells. Thus, in DPH-treated patients with decreased serum T4 and free T4, the observed normal serum TSH when one would expect elevated serum TSH may result from drug-induced inhibition of TRH action on TSH release.",
author = "Surks, {Martin I.} and Ordene, {K. W.} and Mann, {D. N.} and {Kumara Siri}, {M. H.}",
year = "1983",
language = "English (US)",
volume = "56",
pages = "940--945",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Diphenylhydantoin inhibits the thyrotropin response to thyrotropin-releasing hormone in man and rat

AU - Surks, Martin I.

AU - Ordene, K. W.

AU - Mann, D. N.

AU - Kumara Siri, M. H.

PY - 1983

Y1 - 1983

N2 - We studied the effect of diphenylhydantoin (DPH) on TRH-stimulated TSH secretion in four patients (three of whom had hypothyroidism; one treated with L-T4), in euthyroid rats, and in dispersed rat anterior pituitary cells in short term tissue culture. DPH treatment of four patients (100 mg, three times daily for 14 days) caused a 22% decrease in mean serum T4 (P < 0.06), a 31% decrease in mean serum free T4 (P < 0.01), and a 6% decrease in mean serum T3. Mean basal serum TSH was unchanged, but the integrated TSH response after TRH injection (500 μg, iv) decreased 28% (P < 0.06) and 51% (P < 0.01) after 7 and 14 days of DPH treatment, respectively. Changes in the integrated PRL response to TRH did not correlate with those in TSH. Injection of DPH into euthyroid rats (5 mg/100 g BW.day for 9 days) caused a significant decrease in mean serum T4 but no changes in TSH release after TRH treatment. However, 1 h after a large dose of DPH (20 mg/100 g BW), there was a marked reduction (58%) in TRH-induced TSH release. DPH injections into athyreotic rats (5 mg/100 g BW every 8 h for 48 h) caused a significant increase in pituitary TSH (P < 0.01) but no significant decrease in plasma TSH. DPH inhibited TSH release from cultured anterior pituitary cells. In the presence of 10-7 M TRH, DPH (10-4 M) caused a 74% decrease in TSH release (P < 0.001); the inhibition produced by T3 (10-7 M) was only 14% (P < 0.05). These studies suggest that DPH inhibits TRH-induced TSH release in man, euthyroid rats, and cultured rat interior pituitary cells. Thus, in DPH-treated patients with decreased serum T4 and free T4, the observed normal serum TSH when one would expect elevated serum TSH may result from drug-induced inhibition of TRH action on TSH release.

AB - We studied the effect of diphenylhydantoin (DPH) on TRH-stimulated TSH secretion in four patients (three of whom had hypothyroidism; one treated with L-T4), in euthyroid rats, and in dispersed rat anterior pituitary cells in short term tissue culture. DPH treatment of four patients (100 mg, three times daily for 14 days) caused a 22% decrease in mean serum T4 (P < 0.06), a 31% decrease in mean serum free T4 (P < 0.01), and a 6% decrease in mean serum T3. Mean basal serum TSH was unchanged, but the integrated TSH response after TRH injection (500 μg, iv) decreased 28% (P < 0.06) and 51% (P < 0.01) after 7 and 14 days of DPH treatment, respectively. Changes in the integrated PRL response to TRH did not correlate with those in TSH. Injection of DPH into euthyroid rats (5 mg/100 g BW.day for 9 days) caused a significant decrease in mean serum T4 but no changes in TSH release after TRH treatment. However, 1 h after a large dose of DPH (20 mg/100 g BW), there was a marked reduction (58%) in TRH-induced TSH release. DPH injections into athyreotic rats (5 mg/100 g BW every 8 h for 48 h) caused a significant increase in pituitary TSH (P < 0.01) but no significant decrease in plasma TSH. DPH inhibited TSH release from cultured anterior pituitary cells. In the presence of 10-7 M TRH, DPH (10-4 M) caused a 74% decrease in TSH release (P < 0.001); the inhibition produced by T3 (10-7 M) was only 14% (P < 0.05). These studies suggest that DPH inhibits TRH-induced TSH release in man, euthyroid rats, and cultured rat interior pituitary cells. Thus, in DPH-treated patients with decreased serum T4 and free T4, the observed normal serum TSH when one would expect elevated serum TSH may result from drug-induced inhibition of TRH action on TSH release.

UR - http://www.scopus.com/inward/record.url?scp=0020641272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020641272&partnerID=8YFLogxK

M3 - Article

VL - 56

SP - 940

EP - 945

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 5

ER -